MMM
3M Company163.20
-2.50-1.51%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
86.93BP/E (TTM)
26.03Basic EPS (TTM)
6.27Dividend Yield
0.02%Recent Filings
10-Q
Q3 FY2025 results
3M's Q3 sales climbed 3.5% year-over-year to $6.5 billion, with organic growth of 2.6% fueled by strength in safety gear and electronics, though automotive aftermarket lagged. Operating income rose 10% to $1.4 billion, lifting margins to 22.2% from 20.9%, thanks to productivity gains and lower restructuring costs, yet tempered by a $161 million divestiture charge and litigation hits. Diluted EPS from continuing operations fell 38% to $1.55, pressured by Solventum stake valuation swings, but adjusted figures show 10% growth to $2.19. Cash dipped to $4.7 billion after $3.2 billion in PFAS and earplug settlements, while net debt edged up to $7.4 billion amid $1.8 billion maturities offset by issuances. Free cash flow turned positive at $61 million, derived from $723 million operating cash minus $662 million capex. Ongoing PFAS regulatory scrutiny poses persistent risks.
8-K
3M boosts Q3 results, guidance
3M reported Q3 2025 GAAP sales of $6.5 billion, up 3.5% year-over-year, with adjusted organic growth hitting 3.2%. Adjusted operating margin climbed to 24.7%, boosting adjusted EPS 10% to $2.19, while operating cash flow reached $1.8 billion. The company raised full-year adjusted EPS guidance to $7.95-$8.05, signaling stronger margins ahead. Yet litigation costs linger as a key risk.
8-K
Board member retires
8-K
3M boosts EPS guidance
3M reported Q2 2025 GAAP sales of $6.3 billion, up 1.4% year-over-year, but EPS fell 38% to $1.34 amid heavy litigation costs; adjusted figures shone brighter, with sales up 2.3% and EPS climbing 12% to $2.16, while operating margin expanded 2.9 points to 24.5%. All three business groups posted organic growth for the third straight quarter, fueling confidence in the 3M eXcellence model. Tariffs now baked into outlook. Adjusted EPS guidance lifted to $7.75-$8.00, yet litigation drags persist.
10-Q
Q2 FY2025 results
3M's Q2 sales edged up 1.4% to $6.3B, with organic growth of 0.6% driven by electronics and industrial adhesives, though automotive OEM softened. Operating income dipped to $1.1B from $1.3B, pressured by a $281M charge for the New Jersey PFAS settlement, yet margins held at 18.0% amid productivity gains and lower restructuring costs. Diluted EPS from continuing operations fell 38% to $1.34, reflecting litigation hits and a prior-year pension settlement, but adjusted EPS climbed 12% to $2.16 on share repurchases and gains from an investment sale. Cash dropped to $3.7B after $3.1B in PFAS and earplug settlement payments, while net debt rose to $8.9B; free cash flow turned negative at -$1.5B (derived). The fused silica divestiture closed in June for immaterial proceeds. Ongoing PFAS regulatory scrutiny poses persistent risks.
AVY
Avery Dennison Corporation
183.12-0.57
EMR
Emerson Electric Company
134.09-3.17
FUJIF
FUJIFILM Holdings Corp.
22.08+0.00
HON
Honeywell International Inc.
198.26+0.81
MATW
Matthews International Corporat
27.00+0.15
MICLF
Mycronic AB
21.12+0.00
MSFT
Microsoft Corporation
476.39+1.57
NNBR
NN, Inc.
1.22-0.04
PG
Procter & Gamble Company (The)
145.21+0.08
RCMT
RCM Technologies, Inc.
20.92-0.32